top of page
Ongoing Areas of Active Translational Research
Understand how racial and ethnic disparities impact care delivery for patients with immunodeficiency
Elucidate early and mechanism-based biomarkers that define autoinflammatory risk in patients with immunodeficiency
Investigate secondary immune deficiencies related to B-cell-targeted therapies such as rituximab and chimeric antigen receptor (CAR) T-cell therapy
Define how gene defects drive human immune system dysfunction and the clinical presentation of both frequent infections and autoimmunity in patients with immunodeficiency
bottom of page